EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts

Tong Qiao, Zhenjun Zhu iD

Microorganisms · 14.11.2025 · 13 (11) · 2595

DOI: 10.3390/microorganisms13112595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 14.11.2025. Verfasst von Tong Qiao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine & Department of Food Science and Engineering, Jinan University, Guangzhou 510632, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Basic and Applied Basic Research Project, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An increasing number of studies have confirmed that the gut microbiota, especially bacteria, is closely related to the efficacy of immune checkpoint inhibitor (ICI) therapy. However, the effectiveness of multi-kingdom microbiota and their interactions in predicting the therapeutic effect of ICI therapy remains uncertain. We integrated extensive gut metagenomic databases, including 1712 samples of 10 cohorts from 7 countries worldwide, to conduct rigorous differential analysis and co-occurrence network analysis targeting multi-kingdom microbiota (bacteria, fungi, archaea, and virus). We ultimately identified two subtypes (C1 and C2) by employing a weighted similarity network fusion (WSNF) method. Subtype C2 exhibited higher microbial diversity, better treatment response, and improved prognosis compared to subtype C1. Notably, subtype C2 was associated with higher abundance of beneficial genera such as Bacteroides and Kluyveromyces, while subtype C1 contained potentially detrimental taxa like Malassezia. A multi-kingdom model incorporating 32 genera demonstrated superior predictive accuracy for ICI therapy efficacy compared to single-kingdom models. Co-occurrence network analysis revealed a more robust and interconnected microbiome in subtype C2, suggesting a stable gut environment correlates with effective ICI therapy efficacy. This study highlights the potential of a multi-kingdom signature in predicting the efficacy of ICI therapy, offering a novel perspective for personalized therapy in oncology.

Schlagwörter

Stichwörter der Autor:innen

ICI therapyWSNFco-occurrence networksmetagenomic sequencingmulti-kingdom microbiome

Autor:innen und Institutionen

  • Department of Clinical Medicine & Department of Food Science and Engineering, Jinan University, Guangzhou 510632, China.
  • State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330027, China.

ORCID-Profile: Zhenjun Zhu

Förderung

  • Guangzhou Basic and Applied Basic Research Project
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Qiao, T., & Zhu, Z. (2025). Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts. Microorganisms, 13(11), 2595. https://doi.org/10.3390/microorganisms13112595

Vancouver

Qiao T, Zhu Z. Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts. Microorganisms. 2025;13(11):2595. doi:10.3390/microorganisms13112595

BibTeX
@article{Qiao2025,
  author = {Qiao, Tong and Zhu, Zhenjun},
  title = {Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {11},
  pages = {2595},
  doi = {10.3390/microorganisms13112595}
}
Kostenlos starten →